Bionova Scientific® Inaugurates Advanced Plasmid DNA Production Facility in Texas to Support Surging Global Demand for Cell and Gene Therapy Materials Bionova Scientific®, a full-service biologics contract development and manufacturing organization (CDMO) and a wholly owned subsidiary of the global…
Newron Pharmaceuticals Launches Pivotal Phase III ENIGMA-TRS Program, Randomizing First Patients to Evaluate Evenamide as an Add-On Therapy in Treatment-Resistant Schizophrenia Newron Pharmaceuticals S.p.A. (SIX: NWRN, XETRA: NP5), a biopharmaceutical company specializing in therapies for diseases affecting the central and…
NorthStar Medical Technologies Appoints Jon Coulter as Non-Executive Chairman, Marking a Key Step in Leadership Succession for Continued Growth in the Radiopharmaceutical Sector NorthStar Medical Technologies, LLC, a recognized global innovator in the development, production, and commercialization of advanced radiopharmaceuticals…
Tahoe Therapeutics Secures $30 Million to Build the World’s Largest Dataset for Training AI-Powered Human Cell Models, Aiming to Transform Precision Medicine Tahoe Therapeutics, a biotechnology company at the intersection of artificial intelligence and cellular biology, has announced the successful…
BioMendics Launches Landmark TAMES-02 Clinical Trial to Advance First-in-Class Therapy for Epidermolysis Bullosa Simplex BioMendics, a clinical-stage biopharmaceutical company specializing in the development of novel therapies for rare dermatologic conditions, has announced the official launch of TAMES-02, a pivotal multicenter,…
BioHub Maryland and Bowie State University Join Forces to Empower the Next Generation of Life Sciences Talent In an ambitious initiative to cultivate a stronger, more diverse workforce in Maryland’s thriving life sciences sector, BioHub Maryland—powered by the Maryland Tech…
Charles River Associates Expands Life Sciences Practice with Appointment of Two Seasoned Industry Leaders Charles River Associates (NASDAQ: CRAI), a globally recognized leader in economic, financial, and management consulting, has announced a strategic expansion of its Life Sciences Practice with…
Roche’s Susvimo Shows Durable Vision Preservation Over Five Years with Twice-Yearly Treatment in Neovascular AMD Roche has released compelling new long-term data highlighting the extended efficacy, safety, and durability of its innovative eye implant therapy, Susvimo® (ranibizumab injection), for individuals…
Altasciences and VoxCell BioInnovation Forge Strategic Partnership to Revolutionize Preclinical Drug Development with 3D Bioprinted Human Tissue Models In a move poised to reshape the landscape of early-stage drug development, Altasciences, a fully integrated drug development solution provider, and VoxCell…
Labcorp Earns IVDR CE-Marking for PGDx elio™ tissue complete, Paving the Way for Expanded Personalized Oncology Testing Across Europe In a milestone achievement that advances the accessibility of precision oncology in Europe, Labcorp (NYSE: LH), a global leader in comprehensive…
Simulations Plus and Polish Academy Scientists Validate AI-Powered Drug Design Models in Breakthrough Discovery Targeting Inflammation and Immune Regulation Simulations Plus, Inc. (Nasdaq: SLP), a prominent developer of modeling and simulation software for the biopharmaceutical industry, in collaboration with the…
Centauri Therapeutics Secures Additional $5.1M from CARB-X to Propel Lead Antibacterial Candidate ABX-01 Into First-in-Human Trials Centauri Therapeutics Limited, an innovative immunotherapy company leveraging a novel platform for combating infectious diseases, announced today it has been awarded an additional $5.1…